Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Not yet recruiting × Gliosarcoma × Photons × Clear all

Phase

Status

Not yet recruiting 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1 CNS 1

Conditions

Carcinoma, Non-Small-Cell Lung 2 Radiation Injuries 1 Prostatic Neoplasms 1 Lung Neoplasms 1 Gliosarcoma 1 Glioblastoma 1 Frailty 1 Breast Neoplasms 1

Interventions

cemiplimab 1 X-Rays 1 Specimen Handling 1 Photons 1 Magnetic Resonance Spectroscopy 1 Actinium 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07422363 2026-03-18

Testing the Combination of Anti-cancer Drugs Actimab-A and Cemiplimab (REGN2810) to Improve Outcomes for Patients With Recurrent Glioblastoma

National Cancer Institute (NCI)

Phase 1 Not yet recruiting

Glioblastoma, Gliosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡